Samuel Justin Sinclair
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel Justin Sinclair has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Caleb J. Siefert
Department of Behavioral Sciences, University of Michigan-Dearborn
2 shared publicationsDaniel Antonius
School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, and the Department of Psychiatry, New York University School of Medicine, New York City
2 shared publicationsGreg Haggerty
Von Tauber Institute for Global Psychiatry/Nassau University Medical Center, East Meadow, New York
2 shared publicationsMark A. Blais
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
2 shared publicationsMichelle B. Stein
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
2 shared publications- Hana Perkey
Georgia Regents University, Summerville Campus, 2500 Walton Way, Augusta, GA 30904, USA
1 shared publication
Latest Publications
- 1 December 2015
- Published by Guilford Publications in Bulletin of the Menninger Clinic
- Vol. 79 (4) , 305-334
Neuropsychological functioning and profile validity on the Personality Assessment Inventory (PAI): An investigation in multiple psychiatric settings
Psychologists in medical settings are frequently tasked with providing comprehensive evaluations of patients with complex medical and psychiatric conditions. In order to achieve these aims, standardized measures of neurocognitive and psychological functioning are often employed to empirically assess a patient's level of functioning across an array of relevant clinical domains. However, less is known about the degree to which cognitive impairment affects a patient's ability to complete these more comprehensive assessments, raising questions about test validity. The current study sought to contribute to this growing body of literature by examining whether neurocognitive functioning is associated with profile validity on the Personality Assessment Inventory (PAI) in both outpatient (N = 321) and inpatient (N = 131) psychiatric settings. In Study 1, results indicate that while multiple cognitive domains are associated with overall profile validity in psychiatric outpatients, attentional impairment specificall...
- 1 December 2015
- Published by Guilford Publications in Bulletin of the Menninger Clinic
- Vol. 79 (4) , 305-334
Neuropsychological functioning and profile validity on the Personality Assessment Inventory (PAI): An investigation in multiple psychiatric settings
Psychologists in medical settings are frequently tasked with providing comprehensive evaluations of patients with complex medical and psychiatric conditions. In order to achieve these aims, standardized measures of neurocognitive and psychological functioning are often employed to empirically assess a patient's level of functioning across an array of relevant clinical domains. However, less is known about the degree to which cognitive impairment affects a patient's ability to complete these more comprehensive assessments, raising questions about test validity. The current study sought to contribute to this growing body of literature by examining whether neurocognitive functioning is associated with profile validity on the Personality Assessment Inventory (PAI) in both outpatient (N = 321) and inpatient (N = 131) psychiatric settings. In Study 1, results indicate that while multiple cognitive domains are associated with overall profile validity in psychiatric outpatients, attentional impairment specificall...
- 1 April 2015
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 58, 205-212
External validity of the Symptom Assessment-45 Questionnaire (SA-45) in a clinical sample
- 1 April 2015
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 58, 205-212
External validity of the Symptom Assessment-45 Questionnaire (SA-45) in a clinical sample
- 7 August 2014
- Published by Taylor & Francis in Journal of Personality Assessment
- Vol. 97 (2) , 145-152
Extending the Validity of the Personality Assessment Inventory's (PAI) Level of Care Index (LOCI) in Multiple Psychiatric Settings
The purpose of this study was to extend the validity and clinical application of the Level of Care Index (LOCI) from the Personality Assessment Inventory (PAI) in 2 independent psychiatric samples. In Study 1 (N = 201), the LOCI effectively differentiated level of care (inpatients from outpatients), and was also meaningfully associated with risk factors for psychiatric admission (e.g., suicidal ideation, self-harming behavior, previous psychiatric admission, etc.), even after controlling for other demographic variables (range of Cohen's ds = 0.57–1.00). Likewise, the LOCI also incremented other risk indicators (suicide and violence history) and relevant PAI indexes (i.e., Mean Clinical Elevation, and Suicide and Violence Potential) in predicting level of care, and explained an additional 6% to 12% of variance in the target variable. Diagnostic efficiency analyses indicated LOCI scores in the range of 15 to 18 optimize positive and negative predictive power, and classification rate. In Study 2 (N = 96), the LOCI was found to be significantly higher in those with a recent psychiatric admission within the past 6 months (d = 0.64), as compared to those without an admission. Similarly, those who were admitted for suicide risk had significantly higher mean LOCI scores as compared to those who did not (d = 0.70). The clinical implications of these findings and potential application of the LOCI are discussed.
- 7 August 2014
- Published by Taylor & Francis in Journal of Personality Assessment
- Vol. 97 (2) , 145-152
Extending the Validity of the Personality Assessment Inventory's (PAI) Level of Care Index (LOCI) in Multiple Psychiatric Settings
The purpose of this study was to extend the validity and clinical application of the Level of Care Index (LOCI) from the Personality Assessment Inventory (PAI) in 2 independent psychiatric samples. In Study 1 (N = 201), the LOCI effectively differentiated level of care (inpatients from outpatients), and was also meaningfully associated with risk factors for psychiatric admission (e.g., suicidal ideation, self-harming behavior, previous psychiatric admission, etc.), even after controlling for other demographic variables (range of Cohen's ds = 0.57–1.00). Likewise, the LOCI also incremented other risk indicators (suicide and violence history) and relevant PAI indexes (i.e., Mean Clinical Elevation, and Suicide and Violence Potential) in predicting level of care, and explained an additional 6% to 12% of variance in the target variable. Diagnostic efficiency analyses indicated LOCI scores in the range of 15 to 18 optimize positive and negative predictive power, and classification rate. In Study 2 (N = 96), the LOCI was found to be significantly higher in those with a recent psychiatric admission within the past 6 months (d = 0.64), as compared to those without an admission. Similarly, those who were admitted for suicide risk had significantly higher mean LOCI scores as compared to those who did not (d = 0.70). The clinical implications of these findings and potential application of the LOCI are discussed.